Why is Bandaram Pharma falling/rising?

As of 17-Sep, Bandaram Pharma Packtech Ltd's stock price is currently at Rs 32.50, reflecting a decline of Rs 1.48 or 4.36%. The stock has underperformed significantly, with a 1-week return of -1.81% and a 1-month return of -3.27%. It is also trading close to its 52-week low, just 4.62% above that level. The stock's performance today has been particularly poor, underperforming its sector by 4.77%. Despite a rise in delivery volume by 53.89% against the 5-day average, the stock is trading below all its moving averages, indicating a bearish trend. The company has reported a negative return of -26.02% over the past year, despite a slight increase in profits, which suggests that the stock's valuation may not be justified by its earnings growth. In the broader market context, Bandaram Pharma's performance contrasts sharply with the Sensex, which has gained 1.56% over the past week and 2.60% over the past month. This underperformance is indicative of weak long-term fundamentals, as evidenced by a low Return on Capital Employed (ROCE) of 5.74% and a high Debt to EBITDA ratio of 6.31 times, which raises concerns about the company's ability to service its debt. Additionally, the stock's negative results in June, including a significant drop in net sales, further contribute to its declining price. Overall, the combination of weak financial metrics and poor market performance has led to a bearish sentiment surrounding Bandaram Pharma's stock.